Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Shunichiro Fuchigami"'
Autor:
Teruhiko Ito, Ryusuke Tsunoda, Yasuhiro Izumiya, Shunichiro Fuchigami, Kenichi Tsujita, Koichi Kaikita, Tomokazu Ikemoto, Michiko Nagamine, Masafumi Takae, Hiroki Usuku, Hiroshi Shimizu, Hiromi Yoshimura, Seiji Hokimoto
Publikováno v:
Circulation journal : official journal of the Japanese Circulation Society. 81(12)
Autor:
Seigo Sugiyama, Masakazu Matsukawa, Kenji Soejima, Hisao Ogawa, Koji Enomoto, Takashi Uemura, Hitoshi Sumida, Kenji Morihisa, Hiroshige Yamabe, Yasuaki Tanaka, Shunichiro Fuchigami, Koichi Kaikita
Publikováno v:
Thrombosis Research. 124:28-32
Previous studies have shown raised plasma von Willebrand factor (VWF) levels in patients with atrial fibrillation (AF). However, little is known about changes of VWF associated with VWF-cleaving protease (ADAMTS13) in AF. The aim of this study was to
Autor:
Koichi Kaikita, Masakazu Matsukawa, Hisao Ogawa, Shunichiro Fuchigami, Tomohiro Nakagaki, Yasuhiro Nagayoshi, Kenji Soejima, Seigo Sugiyama, Kenichi Tsujita, Sunao Kojima, Yoshinori Nakamura, Kazuteru Fujimoto, Hideki Shimomura, Michihiro Yoshimura, Tsuyoshi Honda
Publikováno v:
The American Journal of Cardiology. 100:758-763
Von Willebrand factor (VWF), a cofactor in platelet adhesion and aggregation, increases hemostasis and thrombosis. Recently, a metalloprotease that cleaves VWF multimers has been identified, namely ADAMTS13. The aim of this study was to investigate t
Autor:
Masakazu Matsukawa, Kenji Soejima, Takamichi Ono, Mitsutoshi Miura, Shunichiro Fuchigami, Hitoshi Sumida, Hisao Ogawa, Seiji Hokimoto, Takashi Uemura, Seigo Sugiyama, Kenichi Tsujita, Kunihiko Matsui, Yuji Miyazaki, Koichi Kaikita, Hiroshige Yamabe
Publikováno v:
Thrombosis and haemostasis. 103(3)
SummaryHigh plasma level of von Willebrand factor (VWF) is a marker of future cardiovascular events in patients at high risk of coronary artery disease (CAD). The purpose of this study was to examine the changes and the prognostic value of plasma VWF
Autor:
Koichi Kaikita, Kenichi Tsujita, Tsuyoshi Honda, Takanori Hayasaki, Naomi Sakashita, Hisao Ogawa, Seigo Sugiyama, Shunichiro Fuchigami, Masakazu Matsukawa, Motohiro Takeya
Publikováno v:
Journal of molecular and cellular cardiology. 44(5)
Although considerable attention has focused on obesity, insulin resistance and abnormal lipid metabolism as coronary risk factors, it remains unclear how these pathogenic factors affect the inflammatory response after myocardial ischemia-reperfusion.
Autor:
Shunichiro Fuchigami, Koichi Kaikita, Kenji Soejima, Mitsutoshi Miura, Masakazu Matsukawa, Tsuyoshi Honda, Kenichi Tsujita, Seigo Sugiyama, Hisao Ogawa
Publikováno v:
Circulation. 116
Background : Increased plasma levels of von Willebrand factor (VWF) has been reported in acute myocardial infarction (AMI), which indicates the injured endothelial damage in occluded coronary arteries. The larger VWF multimers are known to be more ac
Autor:
Kenichi Tsujita, Shunichiro Fuchigami, Tsuyoshi Honda, Yasuhiro Nagayoshi, Sunao Kojima, Seigo Sugiyama, Tomohiro Nakagaki, Koichi Kaikita, Hisao Ogawa, Masakazu Matsukawa, Kenji Soejima
Publikováno v:
Thrombosis research. 122(5)
Increased plasma levels of von Willebrand factor (VWF) have been reported in acute myocardial infarction (AMI). Recently, we showed reduced activity of a VWF-cleaving protease (ADAMTS13) in AMI patients. However, there is no information as to whether
Autor:
Shunichiro Fuchigami, Shuichi Oshima, Toshiaki Yoshida, Katsuo Noda, Hironobu Fukushima, Hisao Ogawa, Seiji Hokimoto, Yukiko Takushi
Publikováno v:
Internal medicine (Tokyo, Japan). 45(10)
A 79-year-old man underwent stent implantation from the proximal site to the left main trunk with one bare metal stent after rotation atherectomy. He received 200 mg/day ticlopidine and 200 mg/day aspirin from 2 days pre-stenting. Subacute thrombosis